Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
KPTI is an amazing firm comprised of driven, engaged and bright employees. I am happy at KPTI but worried about my performance. I am new to this industry and KPTI and the adjustment has not been easy.
O que você mais gosta nos lideres?
They are responsive, accessible and enthusiastic.
Qual é a melhor parte das suas compensações?
The secondary plan that helps cover health care deductibles.
Quais são algumas das melhores coisas da sua equipe?
They are invested in KPTI and work very hard.
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
Employees are engaged and invested.
O que faz você mais feliz no trabalho?
The every day challenges because so many processes are being developed.
Other Employee Reviews for Karyopharm Therapeutics
×